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E
arly detection of emerging public
health threats is very important to
prevent long-term undesired effects
and reduce disease burden globally. Over
the past decade, lateral flow based immuno-
chromatographic tests or rapid diagnostic
tests (RDTs), which are in general based on
light scattering off surface-functionalized
metallic nanoparticles, have emerged as a
quick and cost-effective method to screen
various diseases providing complementary
approaches to conventional medical prac-
tices, such as clinical examination, micro-
scopic analysis, and investigation. RDT
technologies have since provided various
advantages for tackling public health pro-
blems including, but not limited to, more
effective tracking/monitoring of chronic con-
ditions, infectiousdiseases anddrugsof abuse
in at-risk areas, and widespread medical test-
ingbyminimally trainedmedical personnel or
community healthcare workers.120
In parallel, the recent advances in portable
wireless telecommunication technologies,
especially mobile phones, provide remark-
able opportunities for healthcare applications
in a variety of fields including epidemic pre-
paredness, public health monitoring, and dis-
tributed healthcare systems.2131 In addition
to mobile phones, of particular interest are
emerging wearable electronics devices such
as smart watches and glasses with integrated
or attachable inertia sensors, audio-visual ima-
ging and recording devices, and wireless
connectivity.3235 One such promising smart
device, the Google Glass, consists of a voice-
controllable hands-free computing system
with imagingandvideo-recordingcapabilities
and various wireless technologies including
Bluetooth and Wi-Fi (see Figure 1a). By con-
necting with Android mobile phones or
iPhones through Bluetooth, the Google Glass
is also capable of using the cellular device's
telecommunications capabilities to access the
Internet in areas without Wi-Fi and determine
location information via global positioning
systems (GPS) and/or triangulation through
cellular service provider towers.
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ABSTRACT We demonstrate a Google Glass-based rapid diagnostic test (RDT) reader platform capable of
qualitative and quantitative measurements of various lateral flow immunochromatographic assays and similar
biomedical diagnostics tests. Using a custom-written Glass application and without any external hardware
attachments, one or more RDTs labeled with Quick Response (QR) code identifiers are simultaneously imaged
using the built-in camera of the Google Glass that is based on a hands-free and voice-controlled interface and
digitally transmitted to a server for digital processing. The acquired JPEG images are automatically processed to
locate all the RDTs and, for each RDT, to produce a quantitative diagnostic result, which is returned to the
Google Glass (i.e., the user) and also stored on a central server along with the RDT image, QR code, and other
related information (e.g., demographic data). The same server also provides a dynamic spatiotemporal map and
real-time statistics for uploaded RDT results accessible through Internet browsers. We tested this Google Glass-based diagnostic platform using qualitative
(i.e., yes/no) human immunodeficiency virus (HIV) and quantitative prostate-specific antigen (PSA) tests. For the quantitative RDTs, we measured activated
tests at various concentrations ranging from 0 to 200 ng/mL for free and total PSA. This wearable RDT reader platform running on Google Glass combines a
hands-free sensing and image capture interface with powerful servers running our custom image processing codes, and it can be quite useful for real-time
spatiotemporal tracking of various diseases and personal medical conditions, providing a valuable tool for epidemiology and mobile health.
KEYWORDS: Google Glass . rapid diagnostic test reader . colorimetric sensor . lateral flow immunochromatographic assays .
HIV testing . prostate-specific antigen (PSA) test . mobile health
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Leveraging the advantages of these new platforms,
here we introduce an RDT reader technology inte-
grated on the Google Glass. This wearable computa-
tional platform allows for rapid hands-free imaging
and processing of any number of RDTs, which can be
very useful for disease and medical condition testing
and monitoring in remote locations, disaster relief
areas, or quarantine zones. The RDTs to be imaged
can be either held in the user's hand (see Figure 1b)
or laid flat on a surface. Using a Quick Response (QR)
code37 identifier, which is custom-designed and at-
tached to each RDT cassette, this system is capable
of automatically finding and identifying the type of
the RDT of interest, along with other information
(e.g., patient data) that can be linked to the same QR
code. Adding the ability to recognize and process
additional RDT types can then be done on our cen-
tralized servers without any need to update the Google
Glass RDT reader software. Furthermore, our servers
provide a centralized database and Web interface for
visualizing uploaded data in the form of a spatiotem-
poral map, which can be quite useful for short- and
long-term spatiotemporal tracking of the evolution of
infectious diseases and other conditions.
Over the past several years, there has been consider-
able research and development effort to create
automated digital test readers capable of both quali-
tative and quantitative analysis of RDTs.3847 These
have mainly appeared in the form of bulky but high-
throughput desktop readers which generally read only
a specific set of RDTs. More recently, mobile-phone-
based readers capable of working with a number of
tests have also been introduced.4850 For example, in
our previous work,48 we created a compact and cost-
effective RDT reader optical attachment installed
on a cell phone that can work with various lateral
flow immunochromatographic assays to detect the
presence and strength of a target analyte. Other
approaches include LMD (Mobile Assay, CO, USA),
whom use a custom software application running on
a cell phone.51 However, these mobile technologies do
not provide the ability to image and process multiple
RDT tests simultaneously and require manual handling
of both the RDT test and the mobile phone camera.
Here, we replace all the external opto-mechanical
hardware attachments with customized image proces-
sing techniques to create an RDT reader software
application capable of detecting and processingmulti-
ple RDTs imaged using the Google Glass built-in
camera under natural illumination conditions along
with a hands-free sensing and image capture interface.
Therefore, our RDT reader application on Google Glass
retains the mobile interface while allowing for multi-
plexed imaging of various types of RDTs from different
manufacturers. Utilizing the existing camera module
and the continuouswireless connectivity of the Google
Glass, we combine this hands-free sensing and image
capture interface with powerful servers running our
custom image processing codes to merge the advan-
tages of desktop readers with those of mobile readers.
Additionally, our system integrates into a global net-
work of lab-on-a-chip applications, allowing for quick
retrieval of RDT results through the same Google Glass
interface.
We tested this Google Glass-based RDT reader plat-
form through human immunodeficiency virus (HIV)
and prostate-specific antigen (PSA) rapid tests (see
Figure 2) by installing our application on Google Glass
devices obtained as part of the Google Glass Explorer
program. The PSA test is routinely used for prostate
cancer screening and surveillance inmen. Recent work
has suggested that the ratio of free PSA to total PSA
(i.e., free plus those bound to other proteins) and the
rate of increase in PSA level can collectively predict the
presence and aggressiveness of prostate cancer.5255
For our proof-of-concept demonstration experiments,
Figure 1. Labeled Google Glass and demonstration of imaging a rapid diagnostic test (RDT). (a) Front-profile view of the
Google Glass with various hardware components36 labeled. (b) Example of using the Glass for taking an image of an RDT as
part of our RDT reader application.
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we imaged these RDTs under fluorescent illumination
indoor conditions with relatively simple backgrounds,
for example, walls that are commonly found in build-
ings. We believe that this wearable RDT reader plat-
form running on Google Glass can be quite useful for
epidemiology and mobile-health applications by pro-
viding real-time spatiotemporal tracking of various dis-
eases and personal medical conditions through a rapid
hands-free and high-throughput imaging interface.
RESULTS AND DISCUSSION
System Design. As part of our diagnostic system, we
designed a custom Google Glass RDT reader applica-
tion for capturing RDT images, a Web portal for gen-
erating custom QR code-based identifiers and viewing
test results, and the server processes for rapid and
high-throughput digital evaluation of test results from
any number of devices, with results readywithin 8 s per
test (see Figures 3 and 4). After installing the Google
Glass RDT application, the users are able to image new
RDTs and view previously evaluated tests. Users must
first use our custom-designed Web site to input RDT
test information and generate a corresponding QR
code identifier, which can then be attached to the
tests prior to imaging (see Figures 3 and 4). As the
hardware on the Google Glass is ill-suited for compu-
tationally intensive tasks, we do not process test
images on the device. Instead, RDT images are trans-
ferred wirelessly using Wi-Fi or through a Bluetooth-
matched device's wireless connection (e.g., Wi-Fi, GSM,
CDMA, etc.) to our servers for rapid digital processing
and evaluation (see Figure 3b). In case wireless con-
nectivity is not available, test results can be stored
locally on the Google Glass and automatically up-
loaded to our servers for processing once connectivity
becomes available. After evaluation, test results are
securely stored on the server under the Google ac-
count registered with the Glass and also sent back to
the Google Glass and shown to the user in the form of a
Timeline Card populated with the RDT image and test
type-specific results (see Figure 3c).
RDT Reader Application on Google Glass. The RDT reader
application appears on the Google Glass as a static card
in the Google Glass Timeline. Through this digital card,
the user can start the process of taking images of QR
Figure 2. Rapid diagnostic tests used in this work. (a) JAJ
International free PSA test; (b) JAJ International total PSA
test; (c) OraQuick ADVANCERapidHIV-1/2 test; (d) OraQuick
In-Home HIV test (approved by the U.S. Food and Drug
Administration).
Figure 3. Block diagram of the rapid diagnostic test (RDT) imaging and processing workflow (ac) done by the Google Glass
application (red dashed frame) and server processes (green dashed frame). In this case, a single RDT is analyzed.
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code-labeled RDTs. The QR code label for each test is
printed after filling in a form on our custom-designed
Web site (http://devpc02.ee.ucla.edu/rdtonglass), where
the user can input various RDT parameters including the
test type (for exampleOraQuickADVANCE Rapid HIV-1/2
antibody test, OraQuick In-Home HIV test,5659 JAJ Free
PSA, JAJ Total PSA6062), lot number, and patient ID,
etc. (see Figure 4a).
After starting a new test, a camera preview will
appear in the Google Glass viewing window with a
vertical test outline overlay to assist the user in placing
or holding the RDT at a specified distance and orienta-
tion. The size and orientation of the RDT in the
captured image is important for several reasons. All
Google Glass camera system hardware iterations up to
now seem optimized for capturing images >2 ft away
from the camera. These systems did not include an
adjustable lens on the camera, and therefore, they
result in out-of-focus blur for imaging of objects closer
to the Glass. Thus to maximize resolution while pre-
venting significant focus blur, we chose an overlay size
occupying approximately 70% of the vertical resolu-
tion of the Glass. To reduce shadowing on the strip
region by the RDT casing, we orient the overlay
vertically under the assumption that light sources will
be strongest above and below the test cassette. Ad-
ditionally, the activation and imaging procedures for
some RDTs such as the OraQuick HIV tests require the
test remain vertical. After aligning the RDT into the
overlay, the user can then take the image by tapping
on the touchpad of the Glass or through the voice-
activated image capture interface of Glass. In future
iterations, QR code-activated automated imaging can
also be implemented.
The captured Glass image then undergoes Google's
automatic image enhancement to produce a higher con-
trast smoothened image, which typically requires <3 s.
After showing the enhanced image to the user through
the Glass interface, this image is uploaded to our servers
for further processing as detailed in Figure 3. Next, the
server processes the test image, and the result is
returned to the Glass and displayed to the user in the
form of a “result card”, posted to the Timeline (see
Figure 3c), populated with the cropped image region,
test type, test validation (valid/invalid), and assess-
ment of the diagnostic results (positive/negative and/
or concentration level, for qualitative and quantitative
tests, respectively). Evaluated tests can also be viewed
independently on a real-time RDT monitoring server
through an Internet browser. Test results are shown
geographically using Google Maps and in more detail
through a table that is filterable by RDTor specific param-
eters of the patient and/or disease (see Figure 4b).
Glass-Based HIV and PSA Testing Results. We validated
the ability of our Google Glass-based RDT reader plat-
form to perform both qualitative decisions and quan-
titative measurements for several lateral flow-based
immunochromatographic RDTs (see Figure 2). For
qualitative validation, we used the FDA-approved
OraQuick In-Home HIV test and the OraQuick ADVANCE
Rapid HIV-1/2 antibody test (OraSure Technologies,
Inc., PA, USA). For quantitative test validation, we used
free and total PSA Rapid tests (JAJ International, Inc.,
CA, USA). To activate these HIV and PSA tests, we used
OraQuick ADVANCE Rapid HIV-1/2 antibody test kit
positive and negative controls (OraSure Technologies,
Inc., PA, USA) containing HIV-1 andHIV-2 antibodies in
human plasma and free and total PSA positive and
negative controls provided by the test manufacturer
(JAJ International, Inc., CA, USA) containing free PSA
and total PSA (free PSA with PSA-ACT) in serum,
respectively.
We started by evaluating the performance of our
Glass platform for making qualitative decisions on
Figure 4. Our custom-designed Web interface of the QR code generator and real-time rapid diagnostic test (RDT) map
(available at http://devpc02.ee.ucla.edu/rdtonglass). (a) QR code generator takes in and stores the information for one or
more RDTs and produces a QR code identifier to be printed and attached to each physical test. (b) RDTs processed by each
user can be viewed on this Google Maps-powered interface. Results can be sorted/searched by various attributes including
disease type, test location, time and date, RDT type, etc. Image Credit: Google Maps, Imagery ª2014, Digital Globe, U.S.
Geological Survey, USDA Farm Service Agency.
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OraQuick HIV RDTs. After activating these RDTs using
the OraQuick positive controls for HIV-1 and HIV-2
separately and the OraQuick negative control as spe-
cified by the manufacturer, wemarked each RDT using
a QR code identifier generated using our online tool.
We then validated test results visually and confirmed
detection and evaluation of negative and positive
HIV-1 and HIV-2 test lines using our RDT reader. We
note that the OraQuick ADVANCE Rapid HIV-1/2 anti-
body tests and OraQuick In-Home HIV tests did not
have significant differences at the same activation
concentration levels and were thus used interchange-
ably in our testing procedures. To demonstrate the
performance of our Glass software system at identify-
ing “difficult” samples, we also imaged and evaluated
HIV RDTs activated with highly diluted positive control
samples, such that we achieved dilutions of 2-, 3-, 4-, 5-,
and 6-fold by adding phosphate buffer solution (PBS)
to the manufacturer-provided reagent solution used
for activating the HIV RDTs. Visual inspection of these
tests noticed much fainter test line responses for high-
er dilution factors.
To test our platform, we imaged each one of our 31
activatedHIV RDTs up to 50 times each for a total of 281
images. These imageswere capturedwith the RDT held
up vertically in front of the Glass (see Figure 1b) and
included some minor tilts of the RDT plane relative to
the camera and illumination differences caused by
Google's automatic image enhancement, both of which
did not affect our detection accuracy. We first validated
our support vector machine-based (SVM)6365 ap-
proach that requires training a classifier using known
labeled (e.g., yes/no) strip images, using a leave-one-
out cross-validation technique,66 the results of which
are summarized in Table 1a. This technique trains an
SVM classifier on all but one input image and classifies
the remaining image using the trained classifier, re-
peating for all the images in the data set to compile
accuracy statistics.66 This validation achieved correct
diagnosis on all the 281 images of OraQuick ADVANCE
Rapid HIV-1/2 antibody tests for up to even 5 dilution
factors. To further demonstrate the robustness of our
technique for OraQuick RDT HIV classification, we
activated and imaged a new testing set composed of
12 OraQuick In-Home HIV tests (2 with negative con-
trols; 5 with HIV-1 controls and 5 with HIV-2 controls
diluted by 2 to 6). Each of these tests was imaged
up to 35 times for a total of 145 images. We then used
the previously imaged 281 images as training data for a
new SVM classifier and tested the resulting classifier on
these new 145 images, achieving 100% classification
accuracy, that is, correctly diagnosing all the activated
RDTs (see Table 1b). We should emphasize that for the
set of controls we used, the OraQuick ADVANCE Rapid
HIV-1/2 antibody tests and OraQuick In-Home HIV
tests, provided sufficiently similar responses that our
classifier is capable of using images of these tests
“interchangeably” without degradation in classifica-
tion accuracy. Furthermore, while our training data
contained HIV tests activated using positive controls
with dilutions from 1 to 5, our new testing data
contained HIV tests activated with dilutions up to
6, suggesting the possibility that detection of even
fainter test lines may be possible using Glass even
without specifically training the classifier for those
weaker antibody/antigen concentrations.
After successfully validating our qualitative (yes/no)
performance even under highly diluted control
TABLE 1. a
a (a) Support vector machine (SVM) classifier6365 cross-validation results for total training image set of 281 images taken from 18 OraQuick ADVANCE Rapid HIV-1/2 antibody
tests, 3 tests for each concentration level (negative, 1, 2, 3, 4, and 5 dilution). Leave-one-out cross-validation66 trains an SVM classifier on all but one test image
and then tests the trained classifier on the left-out test image. The table compiles validation results for all test images. (b) After training an SVM classifier using all the
281 training images, the SVM classifier is tested on a new test set composed of 145 images taken from 12 OraQuick In-Home HIV tests, 2 tests for each concentration level
(negative, 2, 3, 4, 5, and 6 dilution).
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samples, next we moved to evaluating the perfor-
mance of our Glass platform for making quantitative
measurements of PSA RDTs. We activated these RDTs
using manufacturer-provided controls at 0, 2, 4, 8, 10,
20, 100, and 200 ng/mL concentrations for free PSA
RDTs and at 0, 6, 8, 10, 20, and 40 ng/mL concentrations
for total PSA RDTs. As before, each RDT is marked using
a QR code identifier generated using our online tool
(http://devpc02.ee.ucla.edu/rdtonglass). We activated
and imaged 14 PSA tests, activating 1 at each concen-
tration for free and total PSA and imaging the activated
test up to 10 times each, under the same illumination
conditions with the test held vertically in front of the
Glass (see Figure 1b). After Glass-based imaging and
digital processing of these test images as described in
the Methods section, we were able to observe linearity
between PSA concentration (ng/mL) and the test line
intensity values read for both free and total PSA (see
Figure 5). In our free PSA experiments (Figure 5a),
concentrations above 20 ng/mL start saturating, break-
ing the linearity of our response curves. We should
note that, for assisting early stage diagnosis of cancer,
themost relevant freePSA levels arebelow20ng/mL.61,62
Additionally, to demonstrate the ability of this sys-
tem for multiplexed RDT processing, we imaged using
Glass several sets of the previously activated free PSA
and total PSA RDTs placed next to each other on a table
(see Figure 6). In these 25 images taken with up to four
PSA RDTs per image, we correctly detected and eval-
uated all PSA tests with minimal differences in test line
intensity compared to single RDT images taken in
front of the Glass. Since our methodology normalizes
Figure 5. Calibration curves for free and total PSAunder brightfluorescent illumination. (a) FreePSA calibratedusing samples
taken at 0, 2, 4, 8, 10, and 20 ng/mL (ppb). Additional samples taken at 100 and 200 ng/mL are also shown. (b) Total PSA
calibrated using samples taken at 0, 6, 8, 10, 20, and 40 ng/mL.
Figure 6. Multiplexed prostate-specific antigen rapid diagnostic test (RDT) processing example. (a) Starting with the original
Glass image, the QR codes are detected using either iterative speeded-up robust features (SURF)67 matching or edge-based
locationmodule detection. (b) Afterward, each QR code is reconstructed and read. (c,d) Each test is processed and quantified
to produce a test line value, simultaneously quantifying the free and total PSA (in ng/mL).
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using the control line, general illumination changes as
caused by placing multiple tests farther from the
center of the imaging area (see Figure 6a,b) do not
significantly alter test results compared to those from
single RDT images for the same tests.
In our results presented so far, QR code detection
and processing succeeded in 99.6% of all cases. In a
separate evaluation of our QR code system, we at-
tached QR codes onto >60 activated HIV and PSA RDTs
and took >300 images containing both single RDTs and
multiple RDTs both held vertically in front of the Glass
and laid on a flat surface. Compared to our previous
experiments, we included images of RDTs with motion
blur or misaligned RDTs and at distances spanning
from 0.125 to 1.5 ft. On these images, our system for
finding the relatively blurry QR codes captured by
the Google Glass achieved an accuracy of 96.6%. The
majority of failures during this detection step were
caused during the detection of the RDT either by the
RDT being at a significant out-of-plane tilt compared to
the Glass or frommotion blur when RDTs were held in
front of the Glass camera. Following this detection
step, we tested our system for reconstruction and
reading of the code on those detected QR codes and
achieved a 100% reading rate. We note that the QR
code detection is a significantly harder task com-
pared to its reconstruction and reading, and there-
fore, we expect that any detected codes using Glass
should be successfully read, as shown in this specific
experiment.
Finally, we would like to emphasize that the Google
Glass is still in development (we used the beta Explorer
Edition), and we have been experiencing significant
hardware and software updates throughout our research
and development efforts. In particular, the Google
Glass's inability to focus on close objects affected our
sensitivity in reading test lines, particularly at lower
concentrations. Additionally, even while not using the
processing power of the Glass, we were able to continu-
ously image for approximately 1 h on average before
the Glass required recharging. However, with each
successive iteration of the Glass, we have experienced
better performance and a longer use period and are
thus confident that some of these remaining chal-
lenges will either be entirely solved or alleviated in
future improvements and versions of the Glass.
CONCLUSIONS
In summary, we demonstrated a Google Glass-based
RDT reader application capable of qualitative and
quantitative measurements of various lateral flow as-
says and diagnostic tests. Using a custom-written Glass
application andwithout any external optical hardware,
one or more RDTs labeled with QR codes are imaged
using the built-in camera of the Glass, and digitally
transmitted to a remote server for processing. These
digital test images are automatically processed to
create a quantitative diagnostic result, which is then
returned to the Google Glass user and stored with the
RDT image and other related information on a central
server providing review of diagnostics results via a
world map through geo-tagged data. We demon-
strated the success of this Glass-based platform on
HIV and PSA RDTs. Providing real-time spatiotemporal
tracking/mapping of various diseases and medical
conditions, this smart RDT application for Google Glass
could be quite valuable for epidemiology, mobile
health, and telemedicine applications.
METHODS
Automated Image Processing on the Server. QR Code Detection
and Reconstruction. Once received by the server, each Glass
image is first searched for the presence of our custom QR codes
(see Figure 7). QR codes consist of three large double-layered
square modules in the top-left, top-right, and bottom-left
corners of the QR code along with a number of smaller data
modules filling the remainder of the code. To maximize read-
ability and reduce errors, we use the largest size codes available
(Version 1-H), capable of encoding test identifiers of up to 17-
digit numerals under a high error code correction (ECC) cap-
ability. To make detection easier, we print the QR code's loca-
tion and data modules in blue and red colors, respectively. A
descriptor called speeded-up robust features (SURF)67 is used to
detect scale- and rotation-invariant features in the blue channel
of the RDT image. These SURF descriptors are then matched
against SURF descriptors from a template QR code as demon-
strated in the OpenCV library.68 Detected QR codes are then
mapped back to the template using homographic transforma-
tions to map the RDT back to a vertical orientation withminimal
tilt.
We use the ZXing barcode reader library69 to process the QR
codes and return the embedded identifier. Due to focus blur,
this library is unable to process the cropped images directly.
Instead, we first automatically reconstruct a binary QR code
from the detected QR codes (see Figure 8). From the cropped
QR codes, we automatically remove any remaining white
borders, grayscale the image, and resize to a multiple m
of the known QR code grid size of 21 pixels. We then bin the
m*21 m*21 image pixels into a 21  21 grid by applying a
threshold on the average grayscale pixel intensity in each
m  m block of pixels. This new 21  21 reconstructed QR
code is then processed by the ZXing library to extract the test
identifier.
Furthermore, we also created the capability to use this Glass
platform for multiplexed imaging of RDTs (see Figure 6). For
simple uncluttered backgrounds, we can quickly and easily
detect QR codes by finding the corner location modules as
illustrated in Figure 9. Using an edge detector, we first find
significant edges and fill holes created from enclosed regions.
By subtracting the filled holes from the original edges, for
simple backgrounds (e.g., table tops), we obtain squares indi-
cating the QR code location markers. After eliminating noise by
comparing the area ratios of the detected regions against the
known regularity for QR code squares, we then identify the
orientation and the size of the QR codes in the image by
exploiting the QR code's corner location module pattern. As
an alternative, but more computationally involved, method for
more complicated scenes, iterative SURF feature detection and
matching can also be employed to find all the RDTs within the
Glass image.
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Figure 8. Methodology for QR code reconstruction fromblurry Google Glass images. To produce a QR code that is detectable
using standard libraries, we perform a binned threshold across the image. Reconstructed QR codes contain errors but remain
within the QR code's error correction capabilities.
Figure 9. Methodology for multiplexed QR code detection for simple backgrounds. QR code corner location modules are
found using an edge detector. Filtering by area ratios removes the artificial edges caused by background noise. Matching
the distances between detected square centroids of similar sizes against known QR code regularities allows for detection of
QR codes.
Figure 7. Methodology for finding QR code in a Glass image scene and segmenting the test strip region. Using a generic QR
code template, we match location modules across the image using SURF.67 Detected QR codes are then reconstructed and
processed, and the location is used for ratio-based segmentation of the rapid diagnostic test strip region.
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Test Evaluation from the Strip Region. After confirming that
a valid identifier is attached to the test, we automatically crop
the strip region by using the relative position of the QR code on
the RDT (see Figure 7). In our experiments, we vertically align the
QR code above the strip area and automatically crop a large
rectangular region containing the boundaries of the strip
region. By digitally scanning column-wise down the length of
the strip, we automatically search for strong intensity valleys
corresponding to the control line. A final crop is made using the
inner subset of columns containing the control line. Cropped
strip regions without a strong control line intensity valley in any
significant subset of columns are considered “invalid” tests.
For the OraQuick HIV tests, we used average pixel intensities
down the strip as our descriptor for the SVM classifier6365 (see
Figure 10). To generate these descriptors, we start by converting
from RGB to grayscale and high pass filtering the image to
maximize both the control and test line intensities. To deal with
noise and reflections caused by a thin plastic cover over the strip
region and to reduce general illumination differences across
the strip, we then use a row-wise median filter to collapse the
image into a column vector down the length of the strip. The
pixels beyond the center of the control line serve as our
descriptor for the SVM. The SVM classifier is trained using a
balanced set of HIV RDTs activated using positive and negative
controls and thereafter used for testing newly activated HIV
RDTs (see e.g., Table 1).
For the free and total PSA tests (from JAJ International, Inc.,
CA, USA), we use the ratio of the test line intensity to the control
line intensity as a normalized measure of PSA concentration
(see Figure 11). To reduce illumination differences across the
strip, a row-wise average of the intensity along the green
channel produces a column vector representation of the strip.
To reduce out-of-focus noise, we cross-correlate in the first
spatial derivative the control line peak with the rest of the
strip to statistically determine the most likely test line location.
Normalizing the test line intensity against the control line
intensity produces a reliable and quantified measure of the
test. Using images of free and total PSA taken with known
concentration values (see, e.g., Figure 5), we can then fit stan-
dard curves to determine the concentration of PSA for sets of
RDT images captured under similar illumination conditions.
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